Health and Life Sciences: Enabling Tomorrow's Health-Care Solutions

The coronavirus pandemic has demonstrated the importance of life sciences and cross-sectoral collaboration in crisis management and societal resilience.
Life sciences improve patients’ health and strengthen their confidence in the care and treatment that they receive. Data-driven solutions and scientific advances have a significant impact on developments in prevention, diagnostics, treatment, monitoring, habilitation, and rehabilitation that pave the way for personalized care, or precision medicine.

​​​​​​​Sweden has a flourishing life-sciences environment characterized by close collaboration between academia, health care, and industry, as well as sustained government investment in R&D. Thanks in part to a thriving ecosystem of researchers, experienced serial entrepreneurs, and angel investors, there are many start-ups in the life sciences. Rapidly growing markets include medical devices, such as imaging equipment, orthopedic implants, dialysis equipment, heart-lung machines, and ECG equipment. Swedish companies, such as Getinge and Elekta, offer the global market products and systems that contribute to quality enhancement within health care and life sciences. Sweden aims to be the leader in using digitization and e-health opportunities by the year 2025.
Photo of blood bags being scanned Photo of blood bags being scanned
Vision eHealth 2025 is a national goal set by Sweden to be the leader in using digitization and e-health opportunities by the year 2025.

​​​​​Photo: Naina Helén Jåma/
Photo of blood-tests in labPhoto of blood-tests in lab
Photo: Naina Helén Jåma/
The Nordic-American Life Science Conference is an annual event in New York City connecting US investors with Nordic companies that work on life-sciences advancements.